Mukka Proteins Ltd
Incorporated in 2003, Mukka Proteins
Ltd is a manufacturer and exporter
of Fish Meal and Fish oil[1]
- Market Cap ₹ 1,238 Cr.
- Current Price ₹ 41.2
- High / Low ₹ 56.6 / 30.0
- Stock P/E 28.6
- Book Value ₹ 13.3
- Dividend Yield 0.00 %
- ROCE 18.8 %
- ROE 25.6 %
- Face Value ₹ 1.00
Pros
- Company has delivered good profit growth of 38.4% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 28.8%
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Debtor days have increased from 37.7 to 49.0 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Miscellaneous Industry: Food - Processing - Indian
Part of BSE SmallCap BSE Allcap BSE Fast Moving Consumer Goods BSE IPO
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|
409 | 549 | 604 | 770 | 1,177 | 1,380 | 1,095 | |
385 | 525 | 582 | 723 | 1,091 | 1,274 | 1,021 | |
Operating Profit | 23 | 24 | 22 | 48 | 86 | 105 | 75 |
OPM % | 6% | 4% | 4% | 6% | 7% | 8% | 7% |
2 | 8 | 10 | 7 | 8 | 19 | 19 | |
Interest | 4 | 7 | 8 | 10 | 16 | 25 | 30 |
Depreciation | 2 | 5 | 8 | 9 | 12 | 12 | 13 |
Profit before tax | 19 | 20 | 15 | 36 | 66 | 87 | 51 |
Tax % | 27% | 31% | 29% | 28% | 28% | 15% | |
14 | 14 | 11 | 26 | 48 | 74 | 48 | |
EPS in Rs | 1.10 | 2.00 | 2.34 | 1.60 | |||
Dividend Payout % | -0% | -0% | -0% | -0% | -0% | -0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 28% |
3 Years: | 32% |
TTM: | -23% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 38% |
3 Years: | 123% |
TTM: | -43% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | % |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 26% |
3 Years: | 29% |
Last Year: | 26% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|
Equity Capital | 6 | 6 | 6 | 22 | 22 | 30 | 30 |
Reserves | 38 | 51 | 61 | 76 | 126 | 366 | 369 |
83 | 142 | 159 | 175 | 262 | 365 | 426 | |
74 | 95 | 129 | 119 | 166 | 179 | 79 | |
Total Liabilities | 201 | 293 | 355 | 392 | 575 | 941 | 904 |
49 | 78 | 79 | 83 | 85 | 85 | 96 | |
CWIP | -0 | 2 | 4 | -0 | -0 | -0 | -0 |
Investments | 8 | 4 | 12 | 21 | 21 | 31 | 35 |
144 | 209 | 260 | 289 | 469 | 825 | 774 | |
Total Assets | 201 | 293 | 355 | 392 | 575 | 941 | 904 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|
-20 | -25 | 2 | 5 | -56 | -150 | |
-23 | -28 | -14 | -11 | -3 | -51 | |
34 | 54 | 13 | 15 | 75 | 266 | |
Net Cash Flow | -9 | 1 | 2 | 8 | 15 | 65 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|
Debtor Days | 25 | 23 | 29 | 29 | 35 | 49 |
Inventory Days | 95 | 89 | 106 | 95 | 89 | 136 |
Days Payable | 63 | 63 | 71 | 56 | 51 | 44 |
Cash Conversion Cycle | 57 | 49 | 64 | 68 | 73 | 141 |
Working Capital Days | 63 | 76 | 79 | 77 | 88 | 139 |
ROCE % | 15% | 9% | 18% | 24% | 19% |
Documents
Announcements
-
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
18 Nov - Scrutinizer's report and voting results of EGM held on 16th Nov 2024.
-
Shareholder Meeting / Postal Ballot-Outcome of EGM
16 Nov - Summary of proceedings of 01/2024 EGM held.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
16 Nov - Copies of newspaper advertisement of unaudited financial results (Standalone & Consolidated) of the Company for the quarter and half year ended 30th September 2024.
-
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
14 Nov - Monitoring Agency report on IPO proceeds for Q2 FY2025.
-
Statement Of Deviation & Variation
14 Nov - Statement of deviation in IPO fund utilization.
Business Overview:[1]
MPL manufactures Fish Protein products and supplies fish meal, fish oil and fish soluble paste
which is an essential ingredient in manufacturing of aqua feed (for fish and shrimp), poultry feed (for broiler and layer) and pet food (dog and cat food). Further, fish oil also finds application in pharmaceutical products (Omega-3 pills and related products derived from fish oil), soap manufacturing, leather tanneries and paint industries